Oregon Health & Science University
Portland, Oregon, United States
Purpose
to accelerate the testing of the prototype(s) live attenuated CMV based HIV vaccine in first in human experimental medicine trial
Division
Global Health
Date
July 2014
Region Served
GLOBAL
Committed amount
$28,629,661
Grant topic
HIV
Duration (months)
89
Grantee location
Portland, Oregon, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.